13F HOLDINGS REPORT
RiverVest Venture Management LLC
Quarter ended Q2 2023 · Filed April 27, 2023 · Accession 0001104659-23-051214
Total Value
$86.4M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Mirum Pharmaceuticals, Inc. | MIRM | 1,621,118 | $38.9M | 45.05% |
| 2 | Allakos, Inc. | 01671P100 | 4,887,932 | $21.8M | 25.17% |
| 3 | Reneo Pharmaceuticals, Inc. | 75974E103 | 2,409,220 | $14.4M | 16.67% |
| 4 | Spruce Bioscience, Inc. | SPRB | 2,936,281 | $6.5M | 7.51% |
| 5 | Xilio Therapeutics, Inc. | XLO | 1,441,444 | $4.6M | 5.29% |
| 6 | Vapotherm, Inc. | 922107107 | 423,058 | $278,414 | 0.32% |